株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

抗菌薬の世界市場 - 産業洞察、市場動向、見通し、市場機会の分析 2016年~2024年

Antibacterial Drugs Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

発行 Coherent Market Insights 商品コード 798090
出版日 ページ情報 英文 156 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.93円で換算しております。
Back to Top
抗菌薬の世界市場 - 産業洞察、市場動向、見通し、市場機会の分析 2016年~2024年 Antibacterial Drugs Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024
出版日: 2019年02月26日 ページ情報: 英文 156 Pages
概要

抗菌薬は、気候の変化や、途上国の衛生状態の悪さなどの要因によって引き起こされる細菌性感染症の治療または予防に使用されます。抗菌薬に関連する主な課題は、細菌が抗菌薬に耐性をもつことです。抗菌薬耐性菌の課題に対応するために、新たな抗菌薬の開発に向けた重要な研究が行われています。

当レポートでは、世界の抗菌薬市場を調査し、市場の概要、医薬品クラス・投与経路・流通チャネル・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場範囲

  • レポート概要
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場スニペット:医薬品クラス別
    • 市場スニペット:投与経路別
    • 市場スニペット:流通チャネル別
    • 市場スニペット:地域別
  • コヒーレントオポチュニティマップ(COM)

第3章 市場力学、規制、動向分析

  • マーケットダイナミクス
    • 成長要因
    • 阻害要因
    • 市場機会
  • 影響分析
  • パイプライン分析
  • 償還シナリオ
  • 疫学
  • PESTEL分析
  • 規制シナリオ
  • 新製品の発売
  • 提携・協定
  • 市場動向

第4章 世界の抗菌薬市場:医薬品クラス別

  • イントロダクション
  • ベータラクタム
  • キノロン
  • マクロライド
  • テトラサイクリン
  • アミノグリコシド
  • スルホンアミド
  • フェニコール
  • その他

第5章 世界の抗菌薬市場:投与経路別

  • イントロダクション
  • 経口
  • 局所
  • 非経口
  • その他

第6章 世界の抗菌薬市場:流通チャネル別

  • イントロダクション
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第7章 世界の抗菌薬市場:地域別

  • イントロダクション
  • 北米
  • 中南米
  • 欧州
  • アジア太平洋地域
  • 中東
  • アフリカ

第8章 競争環境

  • ヒートマップ解析
  • 企業プロファイル
    • Novartis AG
    • Allergan
    • Bristol Myers Squibb Company
    • AstraZeneca
    • Johnson and Johnson
    • Merck & Co., Inc.
    • GlaxoSmithKline Plc.
    • Sanofi SA
    • Bayer AG
    • Pfizer Inc.
  • アナリストの意見

第9章 セクション

  • 参考文献
  • 調査方法
  • Coherent Market Insightsについて
目次

Antibacterial drugs are used in treatment or prohibition of bacterial infections caused due to various factors such as climatic changes, unhygienic lifestyle specially in emerging economies and others. Major challenge associated with antibacterial drugs is resistance of bacteria towards it. Significant studies are carried out to develop new antibacterial drugs to combat these problems.

Market Dynamics

Increasing prevalence of infectious diseases is a major factor driving antibacterial drugs market growth. According to World Health Organization (WHO), September 2018, annually around 11 million to 21 million cases of typhoid fever are reported worldwide. Moreover, growing geriatric population susceptible to high risk of bacterial infection, majorly caused due to age related changes in immunology is expected to boost the market growth. The Current Opinion in Microbiology Journal 2016, stated Lower respiratory tract infection (Pneumonia), as the most common cause of infection disease in older patients in the U.S. and estimated it as 6 leading cause of death in the U.S.

However, price control of antibacterial drugs, genetic mutation in aging population, and decrease in financial incentives has distracted the focus of pharmaceutical companies from research and development of antibacterial drugs. In September 2016, AstraZeneca announced an agreement with Pfizer to sell the development and commercialization rights to its late-stage small molecule antibiotics business as AstaZeneca does not find antibiotic research as major area for development in their business

Key features of the study:

  • This report provides in-depth analysis of the antibacterial drugs market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017, as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global antibacterial drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Novartis AG, Allergan, Bristol Myers Squibb Company, AstraZeneca, Johnson and Johnson, Merck & Co., Inc., GlaxoSmithKline Plc. (GSK), Sanofi, Bayer AG, and Pfizer Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global antibacterial drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the antibacterial drugs market

Detailed Segmentation

  • Global Antibacterial Drugs Market, By Drug class:
    • Beta lactams
    • Quinolones Macrolides
    • Tetracycline
    • Aminoglycoside
    • Sulfonamide
    • Phenicols
    • Others
  • Global Antibacterial Drugs Market, By Route of Administration:
    • Oral
    • Topical
    • Parenteral
    • Others
  • Global Antibacterial Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Antibacterial Drugs Market, By Geography:
    • North America
      • By Drug Class:
      • Beta lactams
      • Quinolones Macrolides
      • Tetracycline
      • Aminoglycoside
      • Sulfonamide
      • Phenicols
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Parenteral
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Drug Class:
      • Beta lactams
      • Quinolones Macrolides
      • Tetracycline
      • Aminoglycoside
      • Sulfonamide
      • Phenicols
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Parenteral
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Drug Class:
      • Beta lactams
      • Quinolones Macrolides
      • Tetracycline
      • Aminoglycoside
      • Sulfonamide
      • Phenicols
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Parenteral
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Drug Class:
      • Beta lactams
      • Quinolones Macrolides
      • Tetracycline
      • Aminoglycoside
      • Sulfonamide
      • Phenicols
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Parenteral
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Drug Class:
      • Beta lactams
      • Quinolones Macrolides
      • Tetracycline
      • Aminoglycoside
      • Sulfonamide
      • Phenicols
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Parenteral
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Drug Class:
      • Beta lactams
      • Quinolones Macrolides
      • Tetracycline
      • Aminoglycoside
      • Sulfonamide
      • Phenicols
      • Others
      • By Route of Administration:
      • Oral
      • Topical
      • Parenteral
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Novartis AG *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Allergan
    • Bristol Myers Squibb Company
    • AstraZeneca
    • Johnson and Johnson
    • Merck & Co., Inc.
    • GlaxoSmithKline Plc.
    • Sanofi SA
    • Bayer AG
    • Pfizer Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Class
    • Market Snippet, By Route of Administration
    • Market Snippet, By Distribution channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Reimbursement Scenario
  • Epidemiology
  • Pest Analysis
  • Regulatory Scenario
  • New Product Launches
  • Collaborations and Agreements
  • Market Trends

4. Global Antibacterial Drugs Market, By Drug Class, 2018 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Beta lactams
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Quinolones
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Macrolides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Tetracyclines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Aminoglycosides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Sulphonamides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Phenicols
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)

5. Global Antibacterial Drugs Market, By Route of Administration, 2018 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Parenteral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)

6. Global Antibacterial drugs Market, By Distribution Channel, 2018 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026 (US$ Mn)

7. Global Antibacterial Drugs Market, By Region, 2018 - 2026 (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Drug Class, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Drug Class, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Drug Class, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Class, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Drug Class, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Drug Class, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Route of Administration, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Novartis AG
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Allergan
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bristol Myers Squibb Company
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AstraZeneca
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson and Johnson
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck & Co., Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GlaxoSmithKline Plc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi SA
    • Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bayer AG
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top